INFLIXIMAB, DS-8201a, AZD6738, MYCOPHENOLATE MOFETIL, IMFINZI 50 mg/mL concentrate for solution for infusion.
D6185C00001
Phase 3 small_molecule active
Quick answer
INFLIXIMAB, DS-8201a, AZD6738, MYCOPHENOLATE MOFETIL, IMFINZI 50 mg/mL concentrate for solution for infusion. for Patients with non-small cell lung cancer (NSCLC). is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Patients with non-small cell lung cancer (NSCLC).
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active